Stableford Capital Ii LLC Pfizer Inc Transaction History

Stableford Capital Ii LLC

$253 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $59,742 - $69,120	-1,654 Reduced 22.67%	5,642 $206,000
Q1 2023 Apr 11, 2023	SELL	$39.39 - $51.28 $525,777 - $684,485	-13,348 Reduced 64.66%	7,296 $297,000
Q4 2022 Jan 10, 2023	SELL	$41.75 - $54.5 $55,652 - $72,648	-1,333 Reduced 6.07%	20,644 $999 Million
Q3 2022 Oct 25, 2022	BUY	$43.76 - $53.42 $75,836 - $92,576	1,733 Added 8.56%	21,977 $988,000
Q2 2022 Oct 25, 2022	SELL	$46.53 - $55.17 $80,636 - $95,609	-1,733 Reduced 7.89%	20,244 $997,000
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $60,907 - $72,217	-1,309 Reduced 6.07%	20,244 $997,000
Q1 2022 Apr 11, 2022	BUY	$45.75 - $56.69 $1,372 - $1,700	30 Added 0.14%	21,553 $1.19 Million
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $25,783 - $38,220	-624 Reduced 2.82%	21,523 $1.11 Million
Q3 2021 Oct 18, 2021	SELL	$39.25 - $50.42 $64,605 - $82,991	-1,646 Reduced 6.92%	22,147 $923,000
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $13,933 - $15,783	388 Added 1.66%	23,793 $932,000
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $8,071 - $9,102	241 Added 1.04%	23,405 $848,000
Q4 2020 Feb 02, 2021	BUY	$33.47 - $42.56 $586,461 - $745,736	17,522 Added 310.56%	23,164 $853,000
Q3 2020 Feb 11, 2021	BUY	$31.75 - $37.25 $179,133 - $210,164	5,642 New	5,642 $207,000
Q1 2020 Feb 10, 2021	SELL	$27.03 - $38.62 $392,854 - $561,303	-14,534 Closed	0 $0
Q4 2019 Feb 10, 2021	SELL	$32.92 - $37.36 $13,036 - $14,794	-396 Reduced 2.65%	14,534 $569,000
Q3 2019 Feb 10, 2021	BUY	$32.49 - $42.13 $49,612 - $64,332	1,527 Added 11.39%	14,930 $536,000
Q2 2019 Feb 10, 2021	SELL	$36.98 - $41.52 $48,000 - $53,892	-1,298 Reduced 8.83%	13,403 $581,000
Q1 2019 Feb 10, 2021	SELL	$37.5 - $41.2 $20,662 - $22,701	-551 Reduced 3.61%	14,701 $624,000
Q4 2018 Feb 12, 2021	SELL	$38.47 - $43.86 $55,781 - $63,597	-1,450 Reduced 8.68%	15,252 $666,000
Q3 2018 Feb 10, 2021	SELL	$34.47 - $41.81 $63,907 - $77,515	-1,854 Reduced 9.99%	16,702 $736,000
Q2 2018 Feb 10, 2021	SELL	$32.98 - $35.16 $3,001 - $3,199	-91 Reduced 0.49%	18,556 $673,000
Q1 2018 Feb 10, 2021	BUY	$31.91 - $37.02 $5,424 - $6,293	170 Added 0.92%	18,647 $662,000
Q4 2017 Feb 10, 2021	SELL	$33.26 - $35.29 $918,408 - $974,462	-27,613 Reduced 59.91%	18,477 $669,000
Q3 2017 Feb 10, 2021	BUY	$31.0 - $34.15 $84,847 - $93,468	2,737 Added 6.31%	46,090 $1.65 Million
Q2 2017 Feb 11, 2021	SELL	N/A	-2,737 Reduced 5.94%	43,353 $1.46 Million
Q2 2017 Feb 10, 2021	BUY	N/A	8,467 Added 22.5%	46,090 $1.65 Million
Q1 2017 Feb 10, 2021	BUY	N/A	26,103 Added 226.59%	37,623 $1.29 Million
Q4 2016 Feb 10, 2021	BUY	N/A	11,520	11,520 $374,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stableford Capital Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stableford Capital Ii LLC with notifications on news.

Account